Feature | January 27, 2015

3-D Printed Tissue Offers Viable Option for Tracheal Reconstruction

Printed material can be combined with patient’s own cells for customized tissue segments

3-D printing, tracheal reconstruction, STS, Goldstein, Feinstein Institute

Daniel A. Grande, Ph.D., director of the orthopedic research laboratory at the Feinstein Institute, and Todd Goldstein, an investigator at the Feinstein Institute, part of the North Shore-LIJ Health System, with their MakerBot Replicator desktop 3-D printer that they used to 3-D print cartilage to repair tracheal damage.

January 27, 2015 — Three-dimensional (3-D) printing can effectively create a biodegradable tracheal segment containing a patient’s own cells for use in complex tracheal reconstruction, according to a proof of concept study abstract released at the 51st Annual Meeting of The Society of Thoracic Surgeons.

Traditional treatments for tracheal diseases such as stenosis or malacia (abnormal softening of the tissue) usually involve removal of the affected tracheal segment.

“Three-dimensional printing and tissue engineering has the potential for creation of a custom-designed tracheal replacement prosthesis in the lab so that the affected tracheal segment can be ‘swapped out’ instead of removed,” said lead author Todd Goldstein, Ph.D., of the Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System in New York. “Making a windpipe or trachea is uncharted territory. It has to be rigid enough to withstand coughs, sneezes and other shifts in pressure, yet flexible enough to allow the neck to move freely. With 3-D printing, we were able to construct 3-D printed scaffolding that the surgeons could immediately examine and then we could work together in real time to modify the designs.”

Goldstein and colleagues used a custom-designed MakerBot Replicator 2X Experimental 3-D printer that had been modified by engineers to enable printing of living cells. The printer produces a biodegradable scaffold that can be combined with living cells to create a tracheal segment. The size and shape of the scaffold can be customized for each patient. This is a first for medical research where regular MakerBot PLA Filament was used to 3-D print a custom tracheal scaffolding, which was combined with living cells to create a tracheal segment.

“MakerBot was extremely helpful and consulted on optimizing our design files so they would print better and provided advice on how to modify the MakerBot Replicator 2X Experimental 3-D Printer to print with PLA and the biomaterial,” said Goldstein. “We actually found designs to modify the printer on MakerBot’s Thingiverse website to print PLA with one extruder and the biomaterial with the other extruder. We 3-D-printed the needed parts with our other MakerBot Replicator Desktop 3-D Printer, and used them to modify the MakerBot Replicator 2X Experimental 3-D Printer so that we could better iterate and test our ideas.”

For their study, the researchers made three types of printed segments: empty segments, segments without cells (controls) and segments that had been combined with living cells. The bio-printed cells were tested for viability, proliferation (cell growth and division) and gene expression. The researchers found that the cells survived the printing process, were able to continue dividing and produced the cellular properties expected in healthy tracheal cartilage.

“Our results show that three-dimensional printing can be combined with tissue engineering to effectively produce a partial tracheal replacement graft in vitro,” said Goldstein. “Our data demonstrate that the cartilage cells seeded on the graft retain their biological capability and were able to proliferate at the same rate as native cells.”

The authors said that 3-D printing has the potential to revolutionize medicine; patients are already seeing benefits from the technology in the area of customized prosthetics for limb replacement. Reconstructive craniofacial and cardiothoracic surgeons also have been using 3-D printers to build models for more precise surgical planning. 

“We think the next phase will be integrating three-dimensional printing and tissue engineering to produce customized biological replacement parts,” said Goldstein. “While further development is necessary before a clinical trial would be viable, our results show that 3-D printing technology is a feasible alternative to traditional treatments.”

3-D printed tissue is not yet approved by the U.S. Food and Drug Administration.

For more information: www.sts.org

Related Content

CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
3D printing of the heart and coronary artery tree from a patient's CT scan.
Sponsored Content | Webinar | 3-D Printing| August 09, 2017
Learn how 3-D printing empowers medical device manufacturer Medtronic to bring products to market faster, develop bet
FFR-CT, heartflow

An example of an FFR-CT image, showing the FFR values for all coronary vessel segments and the reduction in hemodynamic flow after specific lesions.

News | CT Angiography (CTA)| July 12, 2017
July 12, 2017 — The American Medical Association (AMA) has granted a Category III Tracking Code for estimated coronar
Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve

An example of Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve.

Technology | Computed Tomography (CT)| July 12, 2017
July 12, 2017 — At the 2017 annual meeting for the Society of Cardiovascular Computed Tomography (SCCT), Ziosoft show
GE Additive and Stryker Announce Additive Manufacturing Partnership
News | 3-D Printing| July 06, 2017
GE Additive and Stryker have entered a partnership agreement to support Stryker’s growth in additive manufacturing. The...
3d printing can aid procedural navigation in transcatheter tricuspid procedures
News | 3-D Printing| June 15, 2017
June 15, 2017 – Structural heart interventions are increasingly applied in patients with severe tricuspid regurgitati
Innovative Cardiovascular Ultrasound Solutions Showcased at ASE 28th Annual Scientific Sessions
News | Cardiovascular Ultrasound| June 01, 2017
June 1, 2017 — More than 50 companies and organizations will display their latest products and services at the Americ
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
News | Cardio-oncology| May 03, 2017
Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (...
3-D-printed Model of Stenotic Intracranial Artery Enables Vessel-Wall MRI Standardization
News | 3-D Printing| April 18, 2017
A collaboration between stroke neurologists at the Medical University of South Carolina (MUSC) and bioengineers at the...
3-D Printed Patch Can Help Mend a ‘Broken’ Heart

This photo shows the 3D-bioprinted cell patch in comparison to a mouse heart. When the patch was placed on a live mouse following a simulated heart attack, the researchers saw significant increase in functional capacity after just four weeks. Image courtesy of Patrick O’Leary, University of Minnesota.

News | Stem Cell Therapies| April 18, 2017
April 18, 2017 — A team of biomedical engineering researchers, led by the University of Minnesota, has created a revo
Overlay Init